Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism

Neuroscience Letters

Volumn 404, Issue 1-2, 2006, Pages 163-165

  Eblan, Michael J ^a   Scholz, Sonja ^b   Stubblefield, Barbara ^a   Gutti, Usha ^a   Goker Alpan, Ozlem ^a   Hruska, Kathleen S ^a   Singleton, Andrew B ^b   Sidransky, Ellen ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Dardarin; Gaucher disease; Lewy bodies; Parkinson disease; Risk factor

Indexed keywords

GLUCOSYLCERAMIDASE;

ARTICLE; CONTROLLED STUDY; GAUCHER DISEASE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; JEW; LEUCINE RICH REPEAT KINASE 2 GENE; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HETEROZYGOTE DETECTION; HUMANS; JEWS; MUTATION; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES;

EID: 33745920808     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.05.032     Document Type: Article

References (17)

1. Aharon-Peretz J., Rosenbaum H., and Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 351 (2004) 1972-1977
2. Brice A. Genetics of Parkinson's disease: LRRK2 on the rise. Brain 128 (2005) 2760-2762
3. Cookson M.R., Xiromerisiou G., and Singleton A. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease. Curr. Opin. Neurol. 18 (2005) 706-711
4. Eblan M.J., Nguyen J., Ziegler S.G., Lwin A., Hanson M., Gallardo M., Weiser R., De Lucca M., Singleton A., and Sidransky E. Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela. Mov. Disord. 21 (2006) 282-283
5. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., Shaw K., Bhatia K.P., Bonifati V., Quinn N.P., Lynch J., Healy D.G., Holton J.L., Revesz T., and Wood N.W. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
6. Goker-Alpan O., Schiffmann R., LaMarca M.E., Nussbaum R.L., McInerney-Leo A., and Sidransky E. Parkinsonism among Gaucher disease carriers. J. Med. Genet. 41 (2004) 937-940
7. Gwin-Hardy K. Genetics of parkinsonism. Mov. Disord. 17 (2002) 645-656
8. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., Pollak P., Brice A., and French Parkinson's Disease Genetics Study Group. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N. Engl. J. Med. 354 (2006) 422-423
9. Lwin A., Orvisky E., Goker-Alpan O., LaMarca M.E., and Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol. Genet. Metab. 81 (2004) 70-73
10. Neudorfer O., Giladi N., Elstein D., Abrahamov A., Turezkite T., Aghai E., Reches A., Bembi B., and Zimran A. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 89 (1996) 691-694
11. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., Michaels V.E., Reed T., Rudolph A., Shults C.W., Singleton A., Foroud T., and Parkinson Study Group-PROGENI Investigators. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365 (2005) 410-412
12. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., and Bressman S.B. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354 (2006) 424-425
13. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., and Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
14. Sidransky E. Gaucher disease and parkinsonism. Mol. Genet. Metab. 84 (2005) 302-304
15. Tayebi N., Walker J., Stubblefield B., Orvisky E., LaMarca M.E., Wong K., Rosenbaum H., Schiffmann R., Bembi B., and Sidransky E. Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?. Mol. Genet. Metab. 79 (2003) 104-109
16. Wong K., Sidransky E., Verma A., Mixon T., Sandberg G.D., Wakefield L.K., Morrison A., Lwin A., Colegial C., Allman J.M., and Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol. Genet. Metab. 82 (2004) 192-207
17. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., and Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607